Dr. Philip Kurochkin, MD

Dr. Kurochkin practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Kurochkin's NPI, 1962931303, was assigned on June 8, 2017. Dr. Kurochkin holds West Virginia license 30420.

Dr. Kurochkin's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Kurochkin's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Kurochkin is also affiliated with St. Mary Medical Center. Dmand AI also links Dr. Kurochkin to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurochkin practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kurochkin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kurochkin is licensed in West Virginia.

CMS data shows 19,050 Medicare services from Dr. Kurochkin across 17 procedure codes in 2024, for 419 Medicare patients. Medicare paid $807,259 for them.

CMS counts 419 Medicare patients who saw Dr. Kurochkin in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kurochkin's median patient age at 71, with 58% women.

In 2024, Dr. Kurochkin wrote 209 Medicare Part D claims for 79 patients. 61% of them were for generic drugs. CMS names the drug for 155 of them, across 4 drugs with 11 or more claims each, at $3,296 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kurochkin for performance year 2024, reported as part of a group. Dr. Kurochkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 19 general payments to Dr. Kurochkin from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $467.